RETRACTED: Effect of Previous Cancer History on Survival of Patients with Different Subtypes of Breast Cancer (Retracted Article)

被引:2
|
作者
Lin, Weixun [1 ]
Chen, Yaokun [1 ]
Ji, Zeqi [1 ]
Chen, Lingzhi [1 ]
Wu, Jinyao [1 ]
Chen, Yexi [1 ]
Li, Zhiyang [1 ]
机构
[1] Shantou Univ Med Coll, Hosp 2, Dept Thyroid Breast & Hernia Surg, Shantou 515041, Guangdong, Peoples R China
关键词
ELIGIBILITY CRITERIA; TRIAL ELIGIBILITY; AGE; STRATEGIES; ADJUVANT; THERAPY; STAGE; WOMEN; RACE;
D O I
10.1155/2022/6116658
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Patients with a previous cancer history (PCA) are routinely excluded from most clinical trials, which may limit the accuracy and universality of clinical trials. We aimed to explore the association between PCA and survival of patients with different molecular subtypes of breast cancer. Patients diagnosed with breast cancer from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2015 were included in this retrospective cohort study. The primary outcome was overall survival (OS), which was calculated from date of diagnosis to date of death or censor date during this period. The relationship between PCA and OS of patients with different molecular subtypes of breast cancer was analyzed by the Kaplan-Meier curves and multivariate Cox proportional-hazards model. A total of 35,640 primary breast cancer patients were included, and 2,038 (5.72%) patients had a PCA. Female genital system cancer (491 cases, 24.09%) was the largest proportion type of previous cancer, and HER2-positive (24,754 cases, 69.46%) breast cancer was the most common subtype. Patients with previous female genital/endocrine system cancer history and other cancers history were associated with a poorer OS in overall patients, and in patients with triple-negative and HER2-positive subtypes (P < 0.05). In patients with Luminal A and Luminal B subtypes, previous other cancers history was related to poor OS (P < 0.05), while female genital/endocrine system cancer history may not influence the OS (P > 0.05). Subgroup analyses presented that PCA was related to poor OS in patients aged 40-64 years and & GE;65 years (P < 0.05), while prognosis in patients aged 18-40 years may not be influenced by PCA (P > 0.05). The impact of PCA on the prognosis of breast cancer patients was related to molecular type, patient age, and type of PCA. In clinical trials of breast cancer, the exclusion criteria for PCA patients may be modified according to the above variables.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] RETRACTED: Breast Cancer Calcifications: Identification Using a Novel Segmentation Approach (Retracted Article)
    Chaudhury, Sushovan
    Rakhra, Manik
    Memon, Naz
    Sau, Kartik
    Ayana, Melkamu Teshome
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2021, 2021
  • [32] RETRACTED: Machine Learning Based Comparative Analysis for Breast Cancer Prediction (Retracted Article)
    Khan, Mohammad Monirujjaman
    Islam, Somayea
    Sarkar, Srobani
    Ayaz, Foyazel Iben
    Ananda, Morsaleen Kabeer
    Tazin, Tahia
    Albraikan, Amani Abdulrahman
    Almalki, Faris A.
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [33] RETRACTED: Early Diagnosis of Breast Cancer Using Image Processing Techniques (Retracted Article)
    Younis, Younis Samir
    Ali, Ali Hasan
    Alhafidhb, Omar Kh Salih
    Yahia, Warif B.
    Alazzam, Malik Bader
    Hamad, Abdulsattar Abdullah
    Meraf, Zelalem
    JOURNAL OF NANOMATERIALS, 2022, 2022
  • [34] RETRACTED: Are circRNAs involved in cancer pathogenesis? (Retracted Article)
    Croce, Carlo M.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (11) : 658 - U21
  • [35] RETRACTED: Invention and Clinical Application of an Oversleeve for Measuring Limb Volume in Postoperative Breast Cancer Patients (Retracted Article)
    Yuan, Yujuan
    Chen, Jia
    Wang, Yadong
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [36] RETRACTED: Elemene for the treatment of lung cancer (Retracted Article)
    Rui, D.
    Xiaoyan, C.
    Taixiang, W.
    Guanjian, L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04):
  • [37] RETRACTED: Effects of Chinese Herbal Formula on Immune Function and Nutritional Status of Breast Cancer Patients (Retracted Article)
    Liu, Min
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [38] RETRACTED: Analysis of Signs and Effects of Surgical Breast Cancer Patients Based on Big Data Technology (Retracted Article)
    Hong, Zhen
    Xu, Qin
    Yan, Xin
    Zhang, Ran
    Ren, Yuanfang
    Tong, Qian
    COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE, 2022, 2022
  • [39] RETRACTED: Nanotechnology for multimodality treatment of cancer (Retracted Article)
    Zhang, Xiao-Ying
    Zhang, Pei-Ying
    ONCOLOGY LETTERS, 2016, 12 (06) : 4883 - 4886
  • [40] RETRACTED: Interventions for dysphagia in oesophageal cancer (Retracted Article)
    Sreedharan, Aravamuthan
    Harris, Keith
    Crellin, Adrian
    Forman, David
    Everett, Simon M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):